Cancer Research Institute
CRI Clinic and Laboratory Integration Program
LOI Deadline
Last updated:
The CRI Clinic and Laboratory Integration Program provides $300,000 to support translational cancer immunology research that bridges laboratory discovery and clinical application. The call targets researchers integrating bench and clinic components into a unified project, with emphasis on accelerating immunological findings into therapeutic development. This annual program runs a two-stage evaluation: letter of intent followed by full proposal.
Details
| Funder | Cancer Research Institute |
| Budget | $300,000 |
| Deadline | 1 December 2026 |
| Consortium | No |
| Application | 2-stage: LOI → full proposal |
| Frequency | Annual |
Eligibility & scope
Supports innovative investigations at the intersection of laboratory discovery and clinical application in cancer immunology, accelerating translation of immunological discoveries into cancer therapies.
Who Should Apply
- •Cancer immunologists with both laboratory and clinical research capability
- •Researchers at academic medical centres or institutions with dual research infrastructure
- •Teams integrating bench discovery with patient-facing or clinical trial components
- •Investigators translating immunological mechanisms into therapeutic strategies
Key Dates
- •Letter of Intent deadline: 1 December 2026
- •Two-stage: LOI review then full proposal submission
- •Annual call cycle
Tips for Applicants
- ✓The LOI must clearly articulate the integration strategy: generic lab-only or clinic-only work will not advance past stage one.
- ✓Cancer Research Institute panels weight feasibility of the translational bridge heavily, include realistic timelines and explicit hand-off points between lab and clinic components.
- ✓Demonstrate institutional buy-in for the dual-track research model; letters from laboratory and clinical department heads strengthen the credibility of the integration.
Frequently Asked Questions
What is the CRI Clinic and Laboratory Integration Program budget?
Each award is up to $300,000.
What research does the CRI Clinic and Laboratory Integration Program fund?
Translational cancer immunology research that integrates laboratory discovery with clinical application, accelerating the development of immunological therapies.
Who should apply to the CRI Clinic and Laboratory Integration Program?
Cancer immunologists with capability in both bench and clinical research, typically based at academic medical centres or institutions with integrated laboratory and clinical infrastructure.
How does the CRI Clinic and Laboratory Integration Program application work?
It is a two-stage process: researchers submit a letter of intent by the December deadline, and those selected advance to full proposal submission.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
CRI Clinical Innovator
Cancer Research InstituteDeadline: 1 Dec 2026$1MClinic and Laboratory Integration Program (CLIP)
Cancer Research InstituteDeadline: 1 Dec 2026Up to $1,000,000 over 3 yearsCRI Lloyd J. Old STAR Program
Cancer Research InstituteDeadline: 15 Jan 2027$1.25MCRI Technology Impact Award
Cancer Research InstituteDeadline: 16 Nov 2026$600,000Clinical Innovator
Cancer Research InstituteDeadline: 1 Dec 2026Up to $1M per trial
Browse Related
Could CRI Clinic and Laboratory Integration Program be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →